BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36207497)

  • 1. Effect of radioactivity outside the field of view on image quality of dedicated breast positron emission tomography: preliminary phantom and clinical studies.
    Satoh Y; Imai M; Ikegawa C; Hirata K; Abo N; Kusuzaki M; Oyama-Manabe N; Onishi H
    Ann Nucl Med; 2022 Dec; 36(12):1010-1018. PubMed ID: 36207497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
    Satoh Y; Motosugi U; Imai M; Onishi H
    Ann Nucl Med; 2020 Feb; 34(2):119-127. PubMed ID: 31768819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of image quality at the detector's edge of dedicated breast positron emission tomography.
    Satoh Y; Motosugi U; Imai M; Omiya Y; Onishi H
    EJNMMI Phys; 2021 Jan; 8(1):5. PubMed ID: 33462645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher breast cancer conspicuity on dbPET compared to WB-PET/CT.
    Nishimatsu K; Nakamoto Y; Miyake KK; Ishimori T; Kanao S; Toi M; Togashi K
    Eur J Radiol; 2017 May; 90():138-145. PubMed ID: 28583624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer.
    Masumoto N; Kadoya T; Sasada S; Emi A; Arihiro K; Okada M
    Breast Cancer Res Treat; 2018 Sep; 171(2):315-323. PubMed ID: 29779072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of dedicated breast positron emission tomography.
    Hashimoto R; Akashi-Tanaka S; Watanabe C; Masuda H; Taruno K; Takamaru T; Ide Y; Kuwayama T; Kobayashi Y; Takimoto M; Nakamura S
    Breast Cancer; 2022 Nov; 29(6):1013-1021. PubMed ID: 35768684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal relaxation parameters of dynamic row-action maximum likelihood algorithm and post-smoothing filter for image reconstruction of dedicated breast PET.
    Satoh Y; Imai M; Hirata K; Asakawa Y; Ikegawa C; Onishi H
    Ann Nucl Med; 2021 May; 35(5):608-616. PubMed ID: 33772738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer.
    Sasada S; Shiroma N; Goda N; Kajitani K; Emi A; Masumoto N; Kadoya T; Arihiro K; Okada M
    Breast Cancer Res Treat; 2019 Oct; 177(3):651-657. PubMed ID: 31267329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer.
    Sakaguchi R; Kataoka M; Kanao S; Miyake KK; Nakamoto Y; Sugie T; Toi M; Mikami Y; Togashi K
    Ann Nucl Med; 2019 Aug; 33(8):570-578. PubMed ID: 31115856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of the fluorine-18-labeled fluorodeoxyglucose dose for clinically dedicated breast positron emission tomography.
    Satoh Y; Sekine T; Omiya Y; Onishi H; Motosugi U
    EJNMMI Phys; 2019 Nov; 6(1):21. PubMed ID: 31784863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which type of breast cancers is undetectable on ring-type dedicated breast PET?
    Sasada S; Masumoto N; Goda N; Kajitani K; Emi A; Kadoya T; Okada M
    Clin Imaging; 2018; 51():186-191. PubMed ID: 29859482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer.
    Sueoka S; Sasada S; Masumoto N; Emi A; Kadoya T; Okada M
    Breast Cancer Res Treat; 2021 May; 187(1):125-133. PubMed ID: 33484374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors.
    Sasada S; Kimura Y; Masumoto N; Emi A; Kadoya T; Arihiro K; Okada M
    Eur J Surg Oncol; 2021 Jul; 47(7):1588-1592. PubMed ID: 33685728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation of a high resolution dedicated breast PET scanner.
    García Hernández T; Vicedo González A; Ferrer Rebolleda J; Sánchez Jurado R; Roselló Ferrando J; Brualla González L; Granero Cabañero D; Del Puig Cozar Santiago M
    Med Phys; 2016 May; 43(5):2261. PubMed ID: 27147338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected Abnormal Uptake in the Breasts at Dedicated Breast PET: Incidentally Detected Small Cancers or Nonmalignant Features?
    Satoh Y; Motosugi U; Omiya Y; Onishi H
    AJR Am J Roentgenol; 2019 Feb; 212(2):443-449. PubMed ID: 30476450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Texture Analysis in the Diagnosis of Primary Breast Cancer: Comparison of High-Resolution Dedicated Breast Positron Emission Tomography (dbPET) and Whole-Body PET/CT.
    Satoh Y; Hirata K; Tamada D; Funayama S; Onishi H
    Front Med (Lausanne); 2020; 7():603303. PubMed ID: 33425949
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image quality evaluation of real low-dose breast PET.
    Satoh Y; Imai M; Ikegawa C; Onishi H
    Jpn J Radiol; 2022 Nov; 40(11):1186-1193. PubMed ID: 35612727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.